Pura Vida Investments, LLC
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 12, 2025), Pura Vida Investments, LLC reported 8 stock positions worth $13.7 million. Its top holding was Beta Bionics (BBNX) at 38.4% of the portfolio, followed by Insight Molecular Diagnostic (IMDX, 21.2%) and Establishment Labs (ESTA, 13.4%). Compared with Q4 2024, it opened 3 new positions, sold out of 4, added to 1 and reduced 2. The biggest buy was a new position in Beta Bionics (BBNX) and the biggest sale an exit from Advisorshares Pure US Cann (MSOS).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001590144
- Portfolio Value
- $13.7M (Q1 2025)
- SEC Filing
- 0001590144-25-000003 ↗ filed May 12, 2025
Holdings Value
Holdings 8 stocks · $13.7M
| BBNX Beta Bionics Inc. | 38.36% | 429,120 | $5.3M | New |
| IMDX Insight Molecular Diagnostic filed as ONCOCYTE CORP | 21.17% | 947,134 | $2.9M | Add +44.7% |
| ESTA Establishment Labs Holdings | 13.41% | 45,000 | $1.8M | Reduce -60.2% |
| NSPR Inspiremd Inc. | 8.85% | 450,517 | $1.2M | No change |
| KMTS Kestra Medical Technologies | 7.28% | 40,000 | $997K | New |
| OM Outset Medical Inc. | 5.72% | 5,000 | $783K | New |
| MGX Metagenomi Therapeutics Inc. | 2.63% | 264,391 | $360K | No change |
| NTRA Natera Inc. | 2.58% | 2,500 | $354K | Reduce -50.0% |
Portfolio Sells Q4 2024 → Q1 2025
Portfolio Buys Q4 2024 → Q1 2025
Options Activity Q4 2024 → Q1 2025
| ISRG Intuitive Surgical Inc. | call | Sold out | 3,500 | $1.8Mbefore exit |
| GKOS Glaukos Corp. | call | Sold out | 12,000 | $1.8Mbefore exit |
| PPH Vaneck Pharmaceutical ETF | put | Sold out | 20,000 | $1.7Mbefore exit |
| NTRA Natera Inc. | call | Sold out | 10,000 | $1.6Mbefore exit |
| BVS Bioventus Inc. Class A | call | Sold out | 150,000 | $1.6Mbefore exit |
| ICUI Icu Medical Inc. | call | Sold out | 10,000 | $1.6Mbefore exit |
| IHI iShares U.S. Medical Devices | put | Sold out | 20,000 | $1.2Mbefore exit |
| INMD Inmode Ltd. | put | Sold out | 50,000 | $835Kbefore exit |
| QTRX Quanterix Corp. | call | Sold out | 75,000 | $797Kbefore exit |
| CSTL Castle Biosciences Inc. | call | Sold out | 25,000 | $666Kbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 19 | $37.0M | ALMR, BBNX, ESTA, IMDX, NVDA |
| Q1 2026 | 17 | $14.9M | IMDX, BBNX, ESTA, CAI, NSPR |
| Q4 2025 | 18 | $26.8M | BBNX, IMDX, ESTA, CAI, NSPR |
| Q3 2025 | 8 | $16.4M | BBNX, IMDX, CAI, ESTA, NSPR |
| Q2 2025 | 8 | $16.6M | BBNX, IMDX, CAI, ESTA, OM |
| Q1 2025 | 8 | $13.7M | BBNX, IMDX, ESTA, NSPR, KMTS |
| Q4 2024 | 9 | $18.1M | ESTA, MSOS, LUNG, QTRX, IMDX |
| Q3 2024 | 16 | $60.8M | MSOS, ESTA, GKOS, NTRA, ISRG |
| Q2 2024 | 25 | $82.7M | ESTA, GKOS, ISRG, NTRA, MSOS |
| Q1 2024 | 30 | $146.8M | EXAS, ESTA, ISRG, QTRX, LYRA |